131
Views
2
CrossRef citations to date
0
Altmetric
Case Reports

Peripheral Neuropathy Associated with Hypereosinophilic Syndrome: A Clinical Therapeutic Success with Capsaicin 8% Patch

ORCID Icon, , &
Pages 155-158 | Received 31 Dec 2019, Accepted 20 Feb 2020, Published online: 30 Mar 2020

References

  • Treede R-D, Jensen TS, Campbell JN, Cruccu G, Dostrovsky JO, Griffin JW, Hansson P, Hughes R, Nurmikko T, Serra J, et al. Neuropathic pain redefinition and a grading system for clinical and research purposes. Neurology. 2008;70(18):1630–1635. doi:10.1212/01.wnl.0000282763.29778.59.
  • Luana C, Ludman T, Bouhassira D, Baron R, Dickenson A, Yarnitsky D, et al. Neuropathic pain. Nat Rev Dis Primers. 2017;16(3):17002. doi:10.1038/nrdp.2017.2.
  • Girach A, Julian T, Varrassi G, Paladini A, Vadalouka A, Zis P. Quality of life in painful peripheral neuropathies: a systematic review. Pain Res Manage. 2019;9:2091960. doi:10.1155/2019/2091960.
  • Lee K, Kim J, Park J. Peripheral neuropathy associated with hypereosinophilic syndrome. Ann Dermatol. 2008; 20(3):149–152. doi:10.5021/ad.2008.20.3.149.
  • Dorfman LJ, Ransom BR, Forno LS, Kelts A. Neuropathy in the hypereosinophilic syndrome. Muscle Nerve. 1983; 6(4):291–298. doi:10.1002/mus.880060408.
  • Bell D, Mackay IG, Pentland B. Hypereosinophilic syndrome presenting as peripheral neuropathy. Postgrad Med J. 1985; 61(715):429–432. doi:10.1136/pgmj.61.715.429.
  • Freynhagen R, Bennett MI. Diagnosis and management of neuropathic pain. BMJ. 2009;339(1):b3002–b3002. doi:10.1136/bmj.b3002.
  • Misra UK, Kalita J, Nair P. Diagnostic approach to peripheral neuropathy. Ann Indian Acad Neurol. 2008; 11(2):89–97. doi:10.4103/0972-2327.41875.
  • Attal N, Bouhassira D, Baron R. Diagnosis and assessment of neuropathic pain through questionnaires. Lancet Neurol. 2018;17(5):456–466. doi:10.1016/S1474-4422(18)30071.
  • Haefeli M, Elfering A. Pain assessment. Eur Spine J. 2006; 15(S1):S17–S24. doi:10.1007/s00586-005-1044-x.
  • Devlin N, Brooks R. EQ-5D and the EuroQol group: past, present and future. Appl Health Econ Health Policy. 2017; 15(2):127–137. doi:10.1007/s40258-017-0310-5.
  • Norma n° 043/2011 da Direção-Geral da Saúde, Tratamento Farmacológico da Dor Neuropática no Adulto e Idoso, https://www.dgs.pt/directrizes-da-dgs/normas-e-circulares-normativas/norma-n-0432011-de-23122011.aspx, de 23/12/2011 atualizada a 13/07/2017
  • Binder A, Baron R. The pharmacological therapy of chronic neuropathic pain. Dtsch Arztebl Int. 2016; 113(37):616–626. doi:10.3238/arztebl.2016.0616.
  • Dobson J, McMillan J, Li L. Benefits of exercise intervention in reducing neuropathic pain. Front Cell Neurosci. 2014; 8:102. doi:10.3389/fncel.2014.00102.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.